HER2-Low Breast Cancer Mirrors HER2-0 in Metastasis Timing but Confers a Survival Edge
A retrospective study of nearly 1,600 patients finds that HER2-low breast cancer behaves like HER2-0 disease in metastatic timing and ...
A retrospective study of nearly 1,600 patients finds that HER2-low breast cancer behaves like HER2-0 disease in metastatic timing and ...
A large multi-institution study found that metastatic breast cancer patients in high deprivation neighborhoods had more TP53 mutations, lower use ...
A large U.S. real-world study found that ESR1 mutations emerging during first-line therapy for ER-positive metastatic breast cancer are linked ...
A real-world study of over 8,500 US patients with ER-positive/HER2-negative metastatic breast cancer found that ESR1 mutation testing remains rare ...
The fight against metastatic breast cancer has taken a significant step forward, as researchers in China have completed one of ...
In a notable advancement in breast cancer treatment, researchers have reported a compelling case of metastatic HER2-positive breast cancer complicated ...
Over the past few decades, medical advancements in cancer treatment have significantly changed the landscape for patients, particularly those diagnosed ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine